We herein uncover a role for p19Arf in limiting the tumor angiogenic switch, demonstrating that loss of Arf expression promotes the angiogenic switch and hastens tumor development, via both p53-dependent and independent mechanisms, in a model of multi-stage carcinogenesis. This evidence concerns the gene CDKN2A and neoplasm.